"Led by Los Angeles ophthalmologist Jonathan Macy, Macy Eye Center offers LASIK, Eyeglasses and contact lenses, cateract surgery, & more! We believe every patient deserves honest, expert diagnoses related to their vision. We will help you make educated decisions about treatment so that you can enjoy the best eyesight possible. To learn more about how Dr. Macy can help you achieve clear vision, or to schedule an appointment at our office in Los Angeles, CA, contact us online or call!"

During the past decade, Macy Eye Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Macy Eye Center" #1 sponsor was "Shire" with 2 trials, followed by "Aerie Pharmaceuticals" with 1 trials sponsored, "Kala Pharmaceuticals, Inc." with 1 trials sponsored, "Kubota Vision Inc." with 1 trials sponsored and "Santen Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Macy Eye Center" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Macy Eye Center" are "Keratoconjunctivitis Sicca" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Blepharitis" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "Macy Eye Center" in a lesser frequency.

Most popular intervention types in "Macy Eye Center" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "Vehicle" (2 trials) and "AR-15512 Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Macy Eye Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Macy Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Macy Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Macy Eye Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".